Oncol Case Rep J | Volume 4, Issue 2 | Research Article | Open Access
Kabulo Katshi Cedric1*, Kapita Izana Marie Jeanne2 and Kishimba Munda Bakatendela Georges3
1Department of Pathology, Dalian Medical University, University of Lubumbashi, China
2Department of Pathology, University of Lubumbashi, Democratic Republic of the Congo
3Department of Urology, Central South University, China
*Correspondance to: Kabulo Katshi Cedric
Fulltext PDFBackground: Prostate cancer is a common malignant tumor in men in China. This study is done in south of china. We talk about present situation of bone health care for prostate cancer patients on androgen deprivation therapy because many study shown how clinicians do not make attention to this side effect (osteoporosis) of androgen deprivation therapy. Objective: In our study, we want to be sure if physicians they wondering about the bone health care from the prostate cancer patient on ADT. Methodology: Administration of Questionnaire. The data collected from individuals, clinicians during annual urological conference meetings, during the period from 2018 to 2020. We wrote down our questionnaires on the papers and gave it to clinicians. Result: In our study from 508 Doctors we found that, each year they have seen many patients with prostate cancer 77%, then 55% use ADT to treat prostate cancer; 56% did not ask patients to complete bone density test, 54% did not ask patients to complete fracture risk assessment; and 63% of them did not put patients in bisphosphonates. Most of them 54% prescribed (put) patients in vitamin D supplementation, 57% in calcium. Conclusion: Androgen Deprivation Therapy (ADT) is a mainstay of Prostate cancer treatment but also increases the risk of osteoporosis and fracture on prostate cancer patients. Most of clinicians are not screening the patient's bone mineral density test, and do not put patients on bisphosphonate, underestimate the risks of osteoporosis and fractures on prostate cancer patients on ADT. We must change guidelines of AUA, EAU, CUA have not claimed any requirement details on controlling bone complications of prostate cancer patients receiving ADT, more strict requirements to clinicians on urological disease guidelines about bone health control for prostate cancer patients receiving ADT.
ADT; Bone health prostate cancer; Androgen deprivation therapy
Cedric KK, Jeanne KIM, Georges KMB. Present Situation of Bone Health Care for Prostate Cancer Patients on Androgen Deprivation Therapy. Oncol Case Report J. 2021;4(2):1038..